Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach.

Ayakaka I, Ackerman S, Ggita JM, Kajubi P, Dowdy D, Haberer JE, Fair E, Hopewell P, Handley MA, Cattamanchi A, Katamba A, Davis JL.

Implement Sci. 2017 Mar 9;12(1):33. doi: 10.1186/s13012-017-0561-4.

2.

An Official American Thoracic Society Research Statement: Implementation Science in Pulmonary, Critical Care, and Sleep Medicine.

Weiss CH, Krishnan JA, Au DH, Bender BG, Carson SS, Cattamanchi A, Cloutier MM, Cooke CR, Erickson K, George M, Gerald JK, Gerald LB, Goss CH, Gould MK, Hyzy R, Kahn JM, Mittman BS, Mosesón EM, Mularski RA, Parthasarathy S, Patel SR, Rand CS, Redeker NS, Reiss TF, Riekert KA, Rubenfeld GD, Tate JA, Wilson KC, Thomson CC; ATS Ad Hoc Committee on Implementation Science..

Am J Respir Crit Care Med. 2016 Oct 15;194(8):1015-1025.

PMID:
27739895
3.

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A.

Clin Infect Dis. 2016 Oct 1;63(7):853-67. doi: 10.1093/cid/ciw566.

PMID:
27621353
4.

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.

Blount RJ, Tran MC, Everett CK, Cattamanchi A, Metcalfe JZ, Connor D, Miller CR, Grinsdale J, Higashi J, Nahid P.

BMC Public Health. 2016 Aug 25;16(1):875. doi: 10.1186/s12889-016-3519-6.

5.

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A.

Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10.

PMID:
27516382
6.

Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model.

Moses MW, Zwerling A, Cattamanchi A, Denkinger CM, Banaei N, Kik SV, Metcalfe J, Pai M, Dowdy D.

Sci Rep. 2016 Jul 29;6:30781. doi: 10.1038/srep30781.

7.

Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis.

Hanrahan CF, Haguma P, Ochom E, Kinera I, Cobelens F, Cattamanchi A, Davis L, Katamba A, Dowdy D.

Open Forum Infect Dis. 2016 May 12;3(2):ofw068. doi: 10.1093/ofid/ofw068. eCollection 2016 Mar.

8.

Empiric TB Treatment of Severely Ill Patients With HIV and Presumed Pulmonary TB Improves Survival.

Katagira W, Walter ND, Den Boon S, Kalema N, Ayakaka I, Vittinghoff E, Worodria W, Cattamanchi A, Huang L, Davis JL.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):297-303. doi: 10.1097/QAI.0000000000000970.

PMID:
26918546
9.

Strategies for implementing implementation science: a methodological overview.

Handley MA, Gorukanti A, Cattamanchi A.

Emerg Med J. 2016 Sep;33(9):660-4. doi: 10.1136/emermed-2015-205461. Epub 2016 Feb 18. Review.

PMID:
26893401
10.

Blood Transcriptional Biomarkers for Active Tuberculosis among Patients in the United States: a Case-Control Study with Systematic Cross-Classifier Evaluation.

Walter ND, Miller MA, Vasquez J, Weiner M, Chapman A, Engle M, Higgins M, Quinones AM, Rosselli V, Canono E, Yoon C, Cattamanchi A, Davis JL, Phang T, Stearman RS, Datta G, Garcia BJ, Daley CL, Strong M, Kechris K, Fingerlin TE, Reves R, Geraci MW.

J Clin Microbiol. 2016 Feb;54(2):274-82. doi: 10.1128/JCM.01990-15. Epub 2015 Nov 18.

11.

Changing Clinician Behavior When Less Is More.

Gonzales R, Cattamanchi A.

JAMA Intern Med. 2015 Dec;175(12):1921-2. doi: 10.1001/jamainternmed.2015.5987. No abstract available.

PMID:
26457364
12.

Investigating Barriers to Tuberculosis Evaluation in Uganda Using Geographic Information Systems.

Ross JM, Cattamanchi A, Miller CR, Tatem AJ, Katamba A, Haguma P, Handley MA, Davis JL.

Am J Trop Med Hyg. 2015 Oct;93(4):733-8. doi: 10.4269/ajtmh.14-0754. Epub 2015 Jul 27.

13.

Theory-Informed Interventions to Improve the Quality of Tuberculosis Evaluation at Ugandan Health Centers: A Quasi-Experimental Study.

Chaisson LH, Katamba A, Haguma P, Ochom E, Ayakaka I, Mugabe F, Miller C, Vittinghoff E, Davis JL, Handley MA, Cattamanchi A.

PLoS One. 2015 Jul 14;10(7):e0132573. doi: 10.1371/journal.pone.0132573. eCollection 2015.

14.

In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection.

Slater M, Tran MC, Platt L, Luu LT, Phan HT, Pham PT, Do TB, Nguyen HT, Gaur RL, Parsonnet J, Cattamanchi A, Luo R, Nahid P, Banaei N.

Diagn Microbiol Infect Dis. 2015 Sep;83(1):41-5. doi: 10.1016/j.diagmicrobio.2015.05.007. Epub 2015 May 19.

PMID:
26081239
15.

Implementing Implementation Science: An Approach for HIV Prevention, Care and Treatment Programs.

Lambdin BH, Cheng B, Peter T, Mbwambo J, Apollo T, Dunbar M, Udoh IC, Cattamanchi A, Geng EH, Volberding P.

Curr HIV Res. 2015;13(3):244-9. Review.

16.

A Clinical Predictor Score for 30-Day Mortality among HIV-Infected Adults Hospitalized with Pneumonia in Uganda.

Koss CA, Jarlsberg LG, den Boon S, Cattamanchi A, Davis JL, Worodria W, Ayakaka I, Sanyu I, Huang L; International HIV-associated Opportunistic Pneumonias (IHOP) Study..

PLoS One. 2015 May 11;10(5):e0126591. doi: 10.1371/journal.pone.0126591. eCollection 2015.

17.

Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis.

Walter ND, Dolganov GM, Garcia BJ, Worodria W, Andama A, Musisi E, Ayakaka I, Van TT, Voskuil MI, de Jong BC, Davidson RM, Fingerlin TE, Kechris K, Palmer C, Nahid P, Daley CL, Geraci M, Huang L, Cattamanchi A, Strong M, Schoolnik GK, Davis JL.

J Infect Dis. 2015 Sep 15;212(6):990-8. doi: 10.1093/infdis/jiv149. Epub 2015 Mar 11.

18.

Tobacco and tuberculosis: could we improve tuberculosis outcomes by helping patients to stop smoking?

Zellweger JP, Cattamanchi A, Sotgiu G.

Eur Respir J. 2015 Mar;45(3):583-5. doi: 10.1183/09031936.00221814. No abstract available.

19.

Health worker perspectives on barriers to delivery of routine tuberculosis diagnostic evaluation services in Uganda: a qualitative study to guide clinic-based interventions.

Cattamanchi A, Miller CR, Tapley A, Haguma P, Ochom E, Ackerman S, Davis JL, Katamba A, Handley MA.

BMC Health Serv Res. 2015 Jan 22;15:10. doi: 10.1186/s12913-014-0668-0.

20.

Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.

Tagmouti S, Slater M, Benedetti A, Kik SV, Banaei N, Cattamanchi A, Metcalfe J, Dowdy D, van Zyl Smit R, Dendukuri N, Pai M, Denkinger C.

Ann Am Thorac Soc. 2014 Oct;11(8):1267-76. doi: 10.1513/AnnalsATS.201405-188OC. Review.

PMID:
25188809

Supplemental Content

Loading ...
Support Center